<link rel="stylesheet" href="https://s3.amazonaws.com/aga-lms-assets/styles/master_styles.css">
<div class="row">
  <!-- Left Side Content -->
  <div class="col-md-7">

    <!-- Book -->

    <nav>
      <div class="nav nav-tabs"
      id="nav-tab"
      role="tablist">
      <a class="nav-item nav-link active"
      id="nav-home-tab"
      data-toggle="tab"
      href="#nav-home"
      role="tab"
      aria-controls="nav-home"
      aria-selected="true">Details</a>
      <a class="nav-item nav-link"
      id="nav-profile-tab"
      data-toggle="tab"
      href="#nav-profile"
      role="tab"
      aria-controls="nav-profile"
      aria-selected="false">Credit Information</a>
      <a class="nav-item nav-link"
      id="nav-profile-tab"
      data-toggle="tab"
      href="#nav-res"
      role="tab"
      aria-controls="nav-res"
      aria-selected="false">Resources</a>
    </div>
  </nav>
  <div class="tab-content"
  id="nav-tabContent">
  <div class="tab-pane fade show active"
  id="nav-home"
  role="tabpanel"
  aria-labelledby="nav-home-tab">
  <!-- Description -->
  <p class="mt-1">In this on demand webcast, Stephen B. Hanauer, MD, AGAF and David T. Rubin, MD, AGAF provide
    an overview of the current body of knowledge on the safety and efficacy of biosimilar products. Biosimilar
    pricing is explored, as well as the impact of payor decisions on clinical GI practice. This activity is a
  collaboration of the AGA Institute and the Crohn's and Colitis Foundation.</p>
  <p>This program is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals,
  Inc. and Pfizer.</p>
  <p class="pt-4 text-center">
    <a href="http://agau.gastro.org/diweb/gateway/init/1/f/catalog*2Fitem*2Feid*2FBIOSIM01"
    class="btn btn-orange"
    <i
    class="fa fa-external-link"></i> Sign in to access</a>
  </p>
  <p><i class="fas fa-info-circle fa-lg"></i>&nbsp;<strong><em>After you sign in, please click the "Launch"
  button on the top of this page to access the videos.</em></strong></p>



</div>
<div class="tab-pane fade"
id="nav-profile"
role="tabpanel"
aria-labelledby="nav-profile-tab">

<h3 class="mt-4">CME / Maintenance of Certification (MOC) Information</h3>
<p>The American Gastroenterological Association (AGA) Institute is accredited by the Accreditation Council
for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.</p>
<p>The AGA Institute designates this enduring activity for a maximum of .5&nbsp;<em>AMA PRA Category 1
Credits</em>™. Physicians should claim only the credit commensurate with the extent of their
participation in the activity.</p>
<p>In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all
  faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held
  within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts
of interest prior to delivering the educational activity to learners.</p>
<p>Successful completion of this CME activity enables the participant to earn up to .5 MOC points in the
  American Board of Internal Medicine’s (ABIM) MOC program. Participants will earn MOC points equivalent to
  the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to
submit participant completion information to ACCME for the purpose of granting ABIM MOC points.</p>
<h4>Faculty Relationship and Financial Disclosures</h4>
<p><strong><a
 href="http://media.mycrowdwisdom.com.s3.amazonaws.com/aga/resources/BIOSIM01_Considerations_Biosimiliars_Financial_Disclosures.pdf"
 title=""
 target="_blank">Click here to view financial disclosures for presenters</a></strong>.</p>
 <p><strong>Planning Committee</strong></p>
 <p>Gary R. Lichtenstein, MD, AGAF</p>
 <p>Consultant: Abbvie, Alaven, Celgene/Santarus/Receptos, Ferring, Hospira, Janssen Orthobiotech,
 Luitpold/American Reagent, Pfizer, Prometheus, Salix Pharmaceuticals,</p>
 <p>Shire, Takeda, UCB</p>
 <p>Grant/Research Support: Celgene/Santarus/Receptos, Takeda</p>
 <p>Honoraria: Clinical Advances in Gastroenterology, Ironwood, McMahon Publishing,</p>
 <p>Merck, Romarck, Springer</p>
 <p>Royalty: SLACK, Inc.</p>
 <p><strong>AGA Staff</strong></p>
 <p>Maura H. Davis</p>
 <p>Disclosed no relevant financial relationships.</p>
 <p>Monique S. Dyson, MS, CHES</p>
 <p>Disclosed no relevant financial relationships.</p>
 <p>Alison Kim, PhD</p>
 <p>Disclosed no relevant financial relationships.</p>
 <p><strong>Crohn’s &amp; Colitis Foundation Staff</strong></p>
 <p>Orna Ehrlich</p>
 <p>Disclosed no relevant financial relationships.</p>
 <p>Laura Wingate</p>
 <p>Disclosed no relevant financial relationships.</p>
 <h4 class="pt-3">&nbsp;</h4>




</div>
<div class="tab-pane fade"
id="nav-res"
role="tabpanel"
aria-labelledby="nav-profile-tab">

<h3 class="mt-4">Additional Resources</h3>

<ul>
  <li>Crohn’s &amp; Colitis Foundation: Biosimilars- What IBD Patients Should Know: <a
   href="http://www.crohnscolitisfoundation.org/resources/biosimilars.html"
   title=""
   target="_blank">www.crohnscolitisfoundation.org/resources/biosimilars.html</a></li>
 </ul>
 <ul>
  <li>U.S. Food &amp; Drug Administration- Information for Healthcare Professionals (Biosimilars): <a
   href="http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/ucm241719.htm"
   title=""
   target="_blank">www.fda.gov/Drugs/DevelopmentApprovalProcess/<br>HowDrugsareDevelopedandApproved/
 ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/ucm241719.htm</a></li>
</ul>

<!-- Pricing -->
<table width="50%"
class="table table-bordered">
<thead>
  <tr style="background-color:#102033; color:#FFFFFF;">
    <th style="padding:2rem;">
      Member
    </th>
    <th style="padding:2rem;">
      Nonmember
    </th>
  </tr>
</thead>
<tbody>
  <tr>
    <td>Free (Sign in to access)</td>
    <td>Free (Sign in to access)</td>
  </tr>
</tbody>
</table>

</div>
</div>

<div class="row">
  <div class="container">
    <div class="row">
      <div class="col-md-12">
        <div class="card mt-3 mb-3">
          <div class="card-body bg-light">
            <h4>Learning objectives</h4>
            <p><i class="fa fa-check"></i> &nbsp; Appreciate the landscape that has contributed to the
              emergence of
            biosimilars in the U.S. IBD market </p>
            <p><i class="fa fa-check"></i> &nbsp; Gain clarity on the definition of biosimilars and the
              abbreviated FDA
            approval pathway</p>
            <p><i class="fa fa-check"></i> &nbsp; Appreciate the rationale for extrapolation of indications
            </p>
            <p><i class="fa fa-check"></i> &nbsp; Know that no biosimilar has received an interchangeable
              designation
            </p>
            <p><i class="fa fa-check"></i> &nbsp; Consider the clinical scenarios in which biosimilars may
              be utilized
            safely</p>


          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="row pt-5">
  <div class="container">
    <hr>
    <p>If you have any questions please email the <a href="mailto:education@gastro.org ">AGA Education
    Department</a>.
  </p>
</div>
</div>
</div>

<!-- Right Side Card Content -->
<div class="col-md-5">
  <!-- * Accomidations * -->
  <div class="container mt-3">
    <div class="row ">
      <div class="card text-light card-case"
      style="background-color:rgb(25, 36, 51); width: 20rem">
      <img src="https://s3.amazonaws.com/aga-lms-assets/images/OnDemand_180x180-1547234219168.jpg"
      class="card-img-top"
      alt="card header image" />
      <div class="card-body">
        <p class="card-text pt-3">
          <i class="fas fa-alarm-clock text-warning fa-2x"></i> Time to Complete: 30 minutes
        </p>
        <p class="card-text pt-3">
          <i class="fas fa-calendar text-warning fa-2x"></i> Released: July 19, 2017
        </p>

        <p class="card-text pt-3">
          <i class="fas fa-calendar-alt text-warning fa-2x"></i> Credit Expires: July 19, 2019
        </p>

        <p class="card-text pt-3 text-center">
          <a href="http://media.mycrowdwisdom.com.s3.amazonaws.com/aga/resources/BIOSIM01_Considerations_Biosimiliars_Financial_Disclosures.pdf"
          target="_blank">
          <button class="btn btn-light btn-orange-on-blue"
          style="background-color:#FAA61A; border:1px solid #FAA61A;"> Disclosures
        </button>
      </a>
    </p>

  </div>
</div>
</div>
</div>
</div>
</div>
